Joint Development Activities. 10.01 Licensee shall have the right during the term of this Agreement to propose to Licensor one or more joint development projects of interest to Licensee and relating to development and/or commercialization of a Conversion Process, which shall be governed by a separate written agreement between the parties which shall not be inconsistent with the terms and conditions of this Agreement. Such projects shall be open to all other Persons as mutually agreed by the Parties and who agree to pay project costs in a manner agreed upon by the parties; provided, however, Licensee shall have the right to proceed alone with funding any such project. 10.02 A project team will be established for each project. Each team will be made up of members from the Parties who will be appointed by the Party they represent. Each Party has full discretion over the selection of their respective team members and reserves the right to modify, change, condition or terminate any such person's membership on the team. 10.03 Each project team will (a) agree upon a budget for the project and the respective obligations of the Parties for project expenses, (b) define the schedule and management controls for each project, (c) identify and assemble the necessary resources, both internal and external to the Parties, for each project, (d) allocate funds and authorize expenditures on a periodic basis related to each project, (e) communicate to Licensor and Licensee the status of the work on a monthly basis, and (f) submit final reports to Licensor and Licensee. The team shall hold meetings on an "as needed" basis at mutually acceptable times and locations to review and discuss the status and results of all projects. 11.
Joint Development Activities. With respect to the *** Licensed Program, from time to time during the License Term, either Party may submit a proposal to the other Party through the Alliance Managers to jointly conduct Development activities specifically designed for the purpose of facilitating Regulatory Approval of a *** Licensed Product in both the Gilead Territory and the MacroGenics Territory (a “Joint Development Activity”). In the event that the Parties mutually agree to conduct such Joint Development Activity, the Parties will (a) agree in writing to a written work plan and time table for conducting such Joint Development Activity and a mechanism for adopting amendments thereto; (b) agree in writing to governance and management mechanisms for such Joint Development Activity, including coordination of such Joint Development Activity through the Alliance Managers; and (c) negotiate in good faith a budget therefor, a mechanism for adopting amendments thereto, and an equitable allocation of costs between the Parties. *** = Portions of this exhibit have been omitted pursuant to a request for confidential treatment. An unredacted version of this exhibit has been filed separately with the Commission.
Joint Development Activities. (i) Either Party may at any time submit to the JPT a proposal to collaborate with the other Party to conduct Clinical Trials or other Development activities in connection with the Development of a JAK Licensed Product; provided that such proposal is submitted in writing as far in advance as reasonably practicable and in any event not later than three (3) months before the planned FPFV. Such proposal shall contain, at a minimum, information supporting the rationale for the proposed activity related to the JAK Licensed Product from a scientific, regulatory and commercial standpoint, as well as an estimated developmental critical path and an estimate of the cost of such Development.
Joint Development Activities. Except for Development activities for which a Party [***] bears the Post-Phase I Development Costs pursuant to Sections 4.6.3 or 4.6.4, with respect to Post-Phase I Development Costs related to Development activities conducted for the purpose of obtaining or maintaining Regulatory Approval for one or more Licensed Products in the Field in the Mersana Territory and at least one Major Market in the Licensee Territory pursuant to the Global Development Plan (collectively, the “Shared Post-Phase I Development Costs”), Licensee and Mersana shall each pay fifty percent (50%) of such Shared Post-Phase I Development Costs ([***], subject to Section 4.7.
Joint Development Activities. Subject to the terms and conditions of this Agreement, Quick-Med and Axxxx will use commercially reasonable efforts during the Term to develop Quick-Med Antimicrobial Technology for use in the Field (the “Joint Development Program”). The Parties will reasonably cooperate on such development. During the Term, Axxxx will conduct one or more evaluations of adhesives treated with Quick-Med Antimicrobial Technology, and Quick-Med will provide basic microbiology analysis to determine the effectiveness of antimicrobial activity imparted thereto.
Joint Development Activities commenting on development activities in centres and corridors to the Regional Planning Authority, preparation and submission of the business case to set-up a company to seek out and undertake joint development activities in the centres and corridors; meeting with and setting up joint development activities.
Joint Development Activities. APPI shall no longer be obligated to sponsor and fund any development activities pursuant to Section III(I).
Joint Development Activities. (a) For so long as (JAE) is employed by SRX and, during the TERM, JAE's activities relating to JOINT DEVELOPMENT shall be allocated to both ALTEA and SRX.
Joint Development Activities. The parties recognize that in the course of their continuing collaboration and efforts to identify optimum solutions to meet customer objectives, certain requirements may be identified for the development of innovative embedded software, processes, hardware design or applications, devices or techniques not presently within the scope of eXI’s product line. The parties agree that in connection with any such development requirement ascertained to exist solely or primarily to enable a customized or optimal solution for Agility’s customers, and where eXI consents, in writing and by form of a cost share agreement, to Agility paying eXI for a portion of the costs associated with such development, Agility will be considered as a development partner in relation to eXI’s development of such innovations. Agility will provide all requisite input regarding the business requirements and upon final development will be entitled to a non-exclusive royalty-free worldwide, irrevocable perpetual license to use such developed intellectual property or invention provided that such intellectual property or invention is manufactured by eXI, subject to eXI’s usual and customary charges for the relevant hardware or equipment itself.
Joint Development Activities. Pursuant to the Transition Services Agreement, SLM BankCo and NewCo will cooperate to jointly complete certain application development projects, including those with respect to ATLAS and [—] (“Joint Development Projects”). SLM BankCo and NewCo shall jointly own all Intellectual Property in all Materials created pursuant to Joint Development Projects (“Joint Materials”). Each Party shall, without limitation, have and retain the right to make, have made, use, lease, import, offer for sale, or sell, have sold and practice methods used in the creation or provision of products or services that incorporate the Joint Materials to the extent that such actions do not infringe upon the intellectual property rights of the other Party. Each Party shall retain the right to grant non-exclusive licenses to any Intellectual Property in the Joint Materials without any payment or accounting to the other Party.
